Stock Earnings

Question 1

Quels sont les états financiers clés de Design Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Design Therapeutics Inc a un total d'actifs de $252, un bénéfice net loss de $-50

Question 2

Quels sont les ratios financiers clés pour DSGN ?

Accepted Answer

Le ratio de liquidité de Design Therapeutics Inc est 28, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Design Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Design Therapeutics Inc data is not available.

Question 4

Design Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Design Therapeutics Inc a un bénéfice net loss de $-50

Question 5

Design Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Design Therapeutics Inc a un passif de 9

Question 6

Combien d'actions en circulation Design Therapeutics Inc a-t-elle ?

Accepted Answer

Design Therapeutics Inc a un total d'actions en circulation de 56.75

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	19	18	21	18	11	2
Research & Development	55	--	57	48	24	6
Operating Expenses	74	62	78	67	35	8
Other Non Operating Income (Expenses)	11	13	11	4	0	0
Pretax Income	-63	-50	-67	-63	-35	-8
Income Tax Expense	--	--	--	--	--	--
Net Income	-63	-50	-67	-63	-35	-8
Net Income Growth	26%	-25%	6%	80%	338%	300%
Shares Outstanding (Diluted)	56.85	57	56	55.71	45.94	53.82
Shares Change (YoY)	0%	2%	1%	21%	-15%	0%
EPS (Diluted)	-1.11	-0.88	-1.19	-1.14	-0.77	-0.15
EPS Growth	24%	-26%	4%	48%	413%	275%
Free Cash Flow	-50	-43	-58	-52	-30	-8
Free Cash Flow Per Share	-0.87	-0.75	-1.03	-0.93	-0.65	-0.14
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-74	-62	-78	-67	-35	-8
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-74	-62	-78	-67	-35	-8
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Design Therapeutics Inc (DSGN) Price